The ‘double hit’ as such, similarly as for the SLC22A16 in OS analysis, point out the relations between physiological, metabolic and signaling pathways of progesterone and the metastatic ability of breast cancer cells, as well as the revival of dormant micrometastases. Here, SLC22A16 is linked to breast carcinoma.